Sincere Co (TSE:7782) Piotroski F-Score: 6 (As of Jul. 02, 2026) — 20% Above Median


TSE:7782 Sincere Co Ltd TSE:7782
77 GF Score
Price 円457.00
GF Value 円668.77
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Sincere Co Piotroski F-Score?

Sincere Co TSE:7782 +0.88% 77 Piotroski F-Score is 6 as of Jul. 02, 2026, which is 20% above its 10-year median of 5.00. GuruFocus rates TSE:7782 with a GF Score™ of 77/100 and a GF Value™ of 円668.77 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 807 Medical Devices & Instruments companies, Sincere Co ranks better than 81.16% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Sincere Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Sincere Co's Piotroski F-Score or its related term are showing as below:

TSE:7782' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 8
Current: 6

During the past 12 years, the highest Piotroski F-Score of Sincere Co was 8. The lowest was 2. And the median was 5.

Sincere Co  (TSE:7782) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Sincere Co Piotroski F-Score Related Terms


Sincere Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Sincere Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sincere Co Piotroski F-Score Chart

Sincere Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 2.00 4.00 5.00 6.00

Sincere Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 0.00 0.00 6.00 0.00

TSE:7782 vs ISRG, BDX, MDLN: Piotroski F-Score Comparison

For the Medical Instruments & Supplies subindustry, Sincere Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sincere Co Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sincere Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Sincere Co's Piotroski F-Score falls into.


TSE:7782
77GF Score
Sincere Co Ltd TSE:7782
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Net Income was 円264 Mil.
Cash Flow from Operations was 円367 Mil.
Revenue was 円7,456 Mil.
Gross Profit was 円2,379 Mil.
Average Total Assets from the begining of this year (Dec24)
to the end of this year (Dec25) was (5496.335 + 5383.494) / 2 = 円5439.9145 Mil.
Total Assets at the begining of this year (Dec24) was 円5,496 Mil.
Long-Term Debt & Capital Lease Obligation was 円465 Mil.
Total Current Assets was 円4,654 Mil.
Total Current Liabilities was 円2,022 Mil.
Net Income was 円302 Mil.

Revenue was 円6,539 Mil.
Gross Profit was 円2,097 Mil.
Average Total Assets from the begining of last year (Dec23)
to the end of last year (Dec24) was (5479.633 + 5496.335) / 2 = 円5487.984 Mil.
Total Assets at the begining of last year (Dec23) was 円5,480 Mil.
Long-Term Debt & Capital Lease Obligation was 円683 Mil.
Total Current Assets was 円4,615 Mil.
Total Current Liabilities was 円2,020 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Sincere Co's current Net Income (TTM) was 264. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Sincere Co's current Cash Flow from Operations (TTM) was 367. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec24)
=264.345/5496.335
=0.04809478

ROA (Last Year)=Net Income/Total Assets (Dec23)
=301.747/5479.633
=0.05506701

Sincere Co's return on assets of this year was 0.04809478. Sincere Co's return on assets of last year was 0.05506701. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Sincere Co's current Net Income (TTM) was 264. Sincere Co's current Cash Flow from Operations (TTM) was 367. ==> 367 > 264 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec24 to Dec25
=464.682/5439.9145
=0.08542083

Gearing (Last Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=682.594/5487.984
=0.12437974

Sincere Co's gearing of this year was 0.08542083. Sincere Co's gearing of last year was 0.12437974. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec25)=Total Current Assets/Total Current Liabilities
=4653.709/2021.644
=2.30194287

Current Ratio (Last Year: Dec24)=Total Current Assets/Total Current Liabilities
=4615.209/2019.648
=2.28515514

Sincere Co's current ratio of this year was 2.30194287. Sincere Co's current ratio of last year was 2.28515514. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Sincere Co's number of shares in issue this year was 6.491. Sincere Co's number of shares in issue last year was 6.388. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=2378.797/7456.078
=0.31904132

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=2096.934/6539.394
=0.32066182

Sincere Co's gross margin of this year was 0.31904132. Sincere Co's gross margin of last year was 0.32066182. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec24)
=7456.078/5496.335
=1.3565545

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec23)
=6539.394/5479.633
=1.1934

Sincere Co's asset turnover of this year was 1.3565545. Sincere Co's asset turnover of last year was 1.1934. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+1+0+0+1
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Sincere Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 6 mean?
Sincere Co (TSE:7782) has a Piotroski F-Score of 6 as of Jul. 02, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Sincere Co and its competitors. This is 20% above median its historical median of 5.00. Over the past decade, Sincere Co's Piotroski F-Score has ranged from 2.00 to 8.00. According to the industry distribution chart, Sincere Co ranks #152 out of 807 companies in the Medical Devices & Instruments industry, placing it in the top 18.8%.
Is Sincere Co's Piotroski F-Score too high?
Sincere Co's current Piotroski F-Score of 6 is 20% above median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Sincere Co's value of 6 is 20% above this industry median. Based on the distribution chart, Sincere Co ranks #152 out of 807 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sincere Co has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sincere Co's Piotroski F-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sincere Co ranks #152 out of 807 companies for Piotroski F-Score. This places Sincere Co in the top 19% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Sincere Co's value of 6 is 20% above this benchmark. Historically, Sincere Co's own Piotroski F-Score has ranged from 2.00 to 8.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Sincere Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 807 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sincere Co's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Sincere Co and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sincere Co's current Piotroski F-Score is 6, which is 20% above median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sincere Co stock overvalued right now?
Based on GuruFocus' analysis, Sincere Co (TSE:7782) is currently considered Significantly Undervalued. The stock's GF Value™ is 円668.77, compared to a current price of 円457.00 — trading 31.7% below its estimated fair value. The current Piotroski F-Score is 6, which is 20% above median its 10-year median of 5.00 and 20% above the Medical Devices & Instruments industry median of 5.00. Sincere Co's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Sincere Co (TSE:7782), the current Piotroski F-Score is 6 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sincere Co (TSE:7782) Overvalued in 2026?

Based on GuruFocus' analysis, Sincere Co stock appears to be undervalued. The current stock price of 円457.00 is trading 31.7% below its estimated GF Value™ of 円668.77. GuruFocus considers Sincere Co to be Significantly Undervalued.

Key valuation signals for TSE:7782:

  • Piotroski F-Score: 6 (20% above median its 10-year median of 5.00)
  • GF Value™: 円668.77 vs. price of 円457.00 (31.7% below fair value)
  • GF Score™: 77/100 with 2 warning signs
  • Industry Position: 20% above the Medical Devices & Instruments median (#152 of 807)

No single metric tells the full story. See the TSE:7782 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sincere Co Business Description

Address 1-28-34 Hongo, Bunkyo-ku, 6th Floor, Hongo MK Building, Tokyo, JPN, 113-0033
Sincere Co Ltd is a Japanese firm engaged in the manufacturing and sale of contact lens.As a company that manufactures and sells contact lenses, which are high-regulated medical devices, it place the highest priority on product safety and quality control, while working closely with company's customers to develop a variety-of-products and sell them at affordable prices to please as many customers as possible. The company opperates domestically as well as internationally.
77GF Score

Get the complete analysis for TSE:7782

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円457.00
Price
円668.77
GF Value